PRESS RELEASE published on 06/02/2026 at 08:00, 5 months 3 days ago Stopzetting van de besprekingen over het Franse CRO-project (LOI van 13/10/25) en prioritering van de internationale doelwitvennootschap (LOI van 19/03/26) Oxurion NV stoppt Übernahmegespräche mit französischer CRO und fokussiert sich auf neue Akquisition. Firmenprofil & Zukunftsaussichten Europa CRO Oxurion NV Klinische Entwicklung Übernahmegespräche
BRIEF published on 05/29/2026 at 18:05, 5 months 7 days ago Oxurion receives transparency notifications from Atlas Special Opportunities II LLC Actions Transparency Atlas Belgium Oxurion
BRIEF published on 05/29/2026 at 18:05, 5 months 7 days ago Oxurion publie des notifications de transparence d'Atlas Special Opportunities II LLC Actions Transparence Belgique Oxurion Opportunités Spéciales Atlas
BRIEF published on 05/29/2026 at 18:05, 5 months 7 days ago Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC Actions Atlas Transparence Belgique Oxurion
BRIEF published on 05/29/2026 at 18:05, 5 months 7 days ago Oxurion Reports Transparency Notifications from Atlas Special Opportunities II LLC Shares Transparency Belgium Atlas Special Opportunities Oxurion
PRESS RELEASE published on 05/29/2026 at 18:00, 5 months 7 days ago Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgevingen volgens Belgische wetgeving over veranderingen in aandelenaantallen. Het bedrijf specialiseert zich in Europese farmaceutische onderaannemers Transparantiekennisgevingen Oxurion NV Belgische Wetgeving Farmaceutische Onderaannemers Aandelenaantallen
PRESS RELEASE published on 05/29/2026 at 18:00, 5 months 7 days ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Oxurion NV receives transparency notifications under Belgian legislation from Atlas Special Opportunities II, LLC regarding changes in shareholding percentages Shareholding Oxurion NV Belgian Legislation Transparency Notifications Atlas Special Opportunities II LLC
BRIEF published on 05/27/2026 at 18:05, 5 months 9 days ago Oxurion annonce une mise à jour des droits de vote suite à la conversion des obligations convertibles Obligations Convertibles Augmentation De Capital Droit De Vote Opportunités Spéciales Atlas Actions Oxurion
BRIEF published on 05/27/2026 at 18:05, 5 months 9 days ago Oxurion Annonce une Augmentation de Capital suite à la Conversion d'Obligations par Atlas Obligations Convertibles Augmentation De Capital Actions Ordinaires Atlas Special Opportunities Oxurion
BRIEF published on 05/27/2026 at 18:05, 5 months 9 days ago Oxurion Announces Voting Rights Update Following Convertible Bonds Conversion Voting Rights Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion Shares
Published on 11/06/2026 at 00:53, 1 hour 30 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 1 hour 38 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 2 hours 28 minutes ago Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/05/2026 at 23:20, 3 hours 3 minutes ago Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/06/2026 at 00:05, 2 hours 18 minutes ago RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period
Published on 11/05/2026 at 22:05, 4 hours 18 minutes ago Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 5 hours 45 minutes ago freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 5 hours 46 minutes ago EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 6 hours 37 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 18:21, 8 hours 1 minute ago Total number of voting rights and shares making up the share capital at October 31, 2026
